8-K - Monte Rosa Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Other Events Effective January 7, 2026, Monte Rosa Therapeutics, Inc. (the “Company”) terminated the sales agreement prospectus (the “ATM Prospectus”) filed w

Other Event

$24.2M

9.01

. Financial Statements and Exhibits (d) Exhibits 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requ

Exhibits Only

Exhibits (1)

8-K